Clinical waste generation from renal units: Implications and solutions

Seminars in Dialysis

Volumn 18, Issue 5, 2005, Pages 396-400

  Hoenich, Nicholas A ^a,d   Levin, Robert ^c   Pearce, Catherine ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c RENAL RESEARCH INSTITUTE   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYVINYLCHLORIDE;

CHRONIC KIDNEY FAILURE; COST BENEFIT ANALYSIS; ECONOMICS; HAZARDOUS WASTE; HOSPITAL DEPARTMENT; HUMAN; RENAL REPLACEMENT THERAPY; REVIEW; WASTE DISPOSAL; WASTE MANAGEMENT;

COST-BENEFIT ANALYSIS; DIETHYLHEXYL PHTHALATE; HAZARDOUS WASTE; HUMANS; KIDNEY FAILURE, CHRONIC; MEDICAL WASTE DISPOSAL; POLYVINYL CHLORIDE; RENAL DIALYSIS; UROLOGY DEPARTMENT, HOSPITAL; WASTE MANAGEMENT;

EID: 27544501767     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.00078.x     Document Type: Review

References (24)

1. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18:52-61, 2005
2. Office of the Deputy Prime Minister: Strategic planning for sustainable waste management. London: HMSO, 2005
3. Clinical waste: a guidance to local authority client officers on the disposal of clinical waste. Northampton: National Association of Waste Disposal Officers (NAWDAO), Institute of Waste Management, 1995
4. Getting sorted: the safe and economic management of hospital waste. Abingdon: Audit Commission Publications, 1997
5. Aspen P, Hawkes J: Clinical waste disposal on Merseyside. London: Audit Commission Inspection Service, 2002
6. Harrad SJ, Jones KC: A source inventory and budget for chlorinated dioxins and furans in the United Kingdom environment. Sci Total Environ 126:89-107, 1992
7. Birnbaum LS, Staskal DF, Diliberto JJ: Health effects of polybrominated dibenzo-p-dioxins (PBDDs) and dibenzofurans (PBDFs). Environ Int 29:855-860, 2003
8. Hankinson O: Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Arch Biochem Biophys 15:379-386, 2005
9. Holliday MG, Ford M, Burrell P, Gould FK: Heat disinfection of clinical waste: microbiological assessment and monitoring of effectiveness. Br J Biomed Sci 57:107-113, 2000
10. Eveillard M, Sarnel C, Fourniat C, Rivoal F, Daroukh A, Huchet J, Chaty M, Hauss S, Bourlioux P: Bacteriological validation of a new apparatus for disinfection of hospital waste at the point of disposal. Infect Control Hosp Epidemiol 22:94-98, 2001
11. Fassbinder W, Frei U, Koch KM: Haemolysis due to formaldehyde-induced anti-N-like antibodies in haemodialysis patients. Klin Wochenschr 57:673-679, 1979
12. Rideout K, Teschke K, Dimich-Ward H, Kennedy SM: Considering risks to healthcare workers from glutaraldehyde alternatives in high-level disinfection. J Hosp Infect 59:4-11, 2005
13. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 37:276-286, 2001
14. Collins AJ, Liu J, Ebben JP: Dialyser reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999. Nephrol Dial Transplant 19:1245-1251, 2004
15. Jonsson S, Ejlertsson J, Ledin A, Mersiowsky I, Svensson BH: Mono- and diesters from o-phthalic acid in leachates from different European landfills. Water Res 37:609-617, 2003
16. Gullett BK, Lemieux PM, Lutes CC, Winterrowd CK, Winters DL: Emissions of PCDD/F from uncontrolled, domestic waste burning. Chemosphere 43:721-725, 2001
17. Noda I, Satkowski MM, Dowrey AE, Marcott C: Polymer alloys of Nodax copolymers and poly (lactic acid). Macromol Biosci 15:269-275, 2004
18. Tickner JA, Schettler T, Guidotti T, McCally M, Rossi M: Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am J Ind Med 39:100-111, 2001
19. Hill SS, Shaw BR, Wu AH: The clinical effects of plasticizers, antioxidants, and other contaminants in medical polyvinylchloride tubing during respiratory and non-respiratory exposure. Clin Chim Acta 304:1-8, 2001
20. Dine T, Luyckx M, Gressier B, Brunet C, Souhait J, Nogarede S, Vanpoucke J, Courbon F, Plusquellec Y, Houin G: A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patients. Med Eng Phys 22:157-165, 2000
21. Wahl HG, Hong Q, Hildenbrand S, Risler T, Luft D, Liebich H: 4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol Dial Transplant 19:2576-2583, 2004
22. Haishima Y, Matsuda R, Hayashi Y, Hasegawa C, Yagami T, Tsuchiya T: Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood circuits during hemodialysis and pump-oxygenation therapy. Int J Pharm 274:119-129, 2004
23. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. Rockville, MD: Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2001
24. Health Canada Expert Advisory Panel on DEHP in Medical Devices: Final Report 2002. Ottawa: Health Canada Medical Devices Bureau, Therapeutic Products Directorate, Health Products and Foods Branch, 2002